The Bill and Melinda Gates Foundation says it will spend $120 million to boost access to generic versions of drugmaker Merck’s antiviral COVID-19 pill for lower income countries, if the drug gets approved by regulators. | Poal: Say what you want.

Welcome • User Guide
ToS • Privacy • Canary
Donate • Bugs • License

©2026 Poal.co

1.5K

•

The Bill and Melinda Gates Foundation says it will spend $120 million to boost access to generic versions of drugmaker Merck’s antiviral COVID-19 pill for lower income countries, if the drug gets approved by regulators. (japantoday.com)

(post is archived)

You are currently inside a comment thread.

Click here to see all the comments (3).

[–] • 0 pt

120 mil is what Bill the globalist has as loose change in his wallet.

link